Articles

Papers, explained in our own words

Every entry summarises what the study set out to test, what it found and why it changes how we design delivery systems. Browse research and reviews or search the collection.

706 articles

Research Review

Showing 1–3 of 3 articles · Keyword: Blood-brain barrier Clear keyword

Current drug targets2026ResearchDrug Delivery

1. Nanomedicine Strategies for Brain-targeted Therapy in Neurological Disorders

Sharma S, Nag P, Vij K, Kalra A, Goel K

Neurological problems are among the world's most significant health issues. Many conditions are considered incurable because current treatments cannot effectively cross the Blood-Brain Barrier (BBB) to exert pharmacological effects. Nanomedicine utilizing various nanoparticles offers a distinct therapeutic approach…

Read the article

Current pharmaceutical design2026ResearchDrug Delivery

2. Rivastigmine and Emerging Nanotechnological Strategies for Targeted Delivery: A Comprehensive Review

Babar E, Ur Rehman A, Gul P, Arshad Ms, Shah Ba, Ahmed N

Alzheimer's disease affects millions of people globally; it is an irreversible and incurable disease, characterized by gradual cognitive decline as well as pathophysiological changes including the presence of senile plaques and neurofibrillary tangles. There are several risk factors associated with Alzheimer's…

Read the article

Current drug delivery2026ResearchDrug Delivery

3. Doxorubicin Nanocarriers in Glioblastoma Therapy: Advances and Limitations

Colpan Rd

Glioblastoma (GBM) remains one of the most aggressive brain malignancies, with limited therapeutic success largely due to the restrictive nature of the Blood-Brain Barrier (BBB) and intrinsic drug resistance mechanisms. Despite standard treatment strategies, the median survival remains approximately 16 months…

Read the article

Let's engineer the next delivery breakthrough together

We co-develop nanocarrier and biosensing programmes with pharma, biotech and academic groups — from target selection through scale-up.

ResearchersRequest a technical consultationTalk formulation, characterisation or assay design with one of our scientists.Industry partnersExplore co-developmentFeasibility studies, co-development programmes and licensing.InvestorsExplore the market opportunitySourced market sizes, pipeline, investment and deal data for genetic medicine delivery.